VNRX-5133-103: A Randomized, Drug-Drug Interaction Study to Assess the Safety and Pharmacokinetics of VNRX-5133 in Healthy Adult Volunteers

Trial Profile

VNRX-5133-103: A Randomized, Drug-Drug Interaction Study to Assess the Safety and Pharmacokinetics of VNRX-5133 in Healthy Adult Volunteers

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Jan 2018

At a glance

  • Drugs VNRX 5133 (Primary) ; VNRX-5022 (Primary)
  • Indications Bacteroides infections
  • Focus Pharmacokinetics
  • Sponsors VenatoRx Pharmaceuticals
  • Most Recent Events

    • 11 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
    • 11 Jan 2018 Status changed from recruiting to active, no longer recruiting.
    • 09 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top